Swelling; Turned red and currently a still swollen; Fever in arm and hot to the touch; Uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling), ERYTHEMA (Turned red and currently a still swollen), FEELING HOT (Fever in arm and hot to the touch) and DISCOMFORT (Uncomfortable) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20a and 037k20a) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date and High cholesterol since an unknown date.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling), ERYTHEMA (Turned red and currently a still swollen), FEELING HOT (Fever in arm and hot to the touch) and DISCOMFORT (Uncomfortable). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swelling), ERYTHEMA (Turned red and currently a still swollen), FEELING HOT (Fever in arm and hot to the touch) and DISCOMFORT (Uncomfortable) had resolved.            Reported Concurrent medications including Blood pressure and cholesterol medications.   This case was linked to MOD21-025114 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up received on 22 Apr 2021 included Updated outcome of the event peripheral swelling, erythema, feeling hot and discomfort from unknown to resolved. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling), ERYTHEMA (Turned red and currently a still swollen), FEELING HOT (Fever in arm and hot to the touch) and DISCOMFORT (Uncomfortable) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20a and 037k20a) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date and High cholesterol since an unknown date.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swelling), ERYTHEMA (Turned red and currently a still swollen), FEELING HOT (Fever in arm and hot to the touch) and DISCOMFORT (Uncomfortable). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swelling), ERYTHEMA (Turned red and currently a still swollen), FEELING HOT (Fever in arm and hot to the touch) and DISCOMFORT (Uncomfortable) had resolved.            Reported Concurrent medications including Blood pressure and cholesterol medications.   This case was linked to MOD21-025114 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: Follow up received on 22 Apr 2021 included Updated outcome of the event peripheral swelling, erythema, feeling hot and discomfort from unknown to resolved.